Clinical trial
Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive…
NCT00158509 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Completed
Key facts
| NCT number | NCT00158509 |
|---|---|
| Title | Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding |
| Official title | Efficacy of an HSV2 Genital Herpes Suppressive Treatment on HIV and HSV2 Genital Shedding Among Co-Infected Patients Receiving or Not Antiretroviral Drugs |
| Lead sponsor | French National Agency for Research on AIDS and Viral Hepatitis, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Herpes Genitalis, HIV Infection |
| Intervention type | Drug |
| Interventions | Valacyclovir |
| Enrollment | 215 |
| Start date | Aug 1, 2004 |
| Completion | Jul 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Jun 7, 2006 |
| Countries | Burkina Faso |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: